Evaluating a vaccine for gonorrhea
Task 12: Sexually Transmitted Infections Clinical Trials Group: Phase 2 Clinical Trial to Evaluate a Vaccine Candidate for Neisseria Gonorrhoeae
This study is testing a new vaccine to help prevent gonorrhea, a common sexually transmitted infection, and is looking for participants to receive the vaccine and help us learn how well it works and how safe it is.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11041791 on NIH RePORTER |
What this research studies
This research focuses on testing a vaccine candidate aimed at preventing gonorrhea, a common sexually transmitted infection caused by Neisseria gonorrhoeae. Participants will be involved in a Phase 2 clinical trial, which means they will receive the vaccine and be monitored for safety and effectiveness. The study will include various clinical sites with trained personnel who will oversee the administration of the vaccine and collect biological samples for analysis. This trial aims to gather important data that could lead to a viable vaccine for gonorrhea.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals at risk for gonorrhea or those who have previously been diagnosed with the infection.
Not a fit: Patients who are not sexually active or those who have no history of sexually transmitted infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of an effective vaccine against gonorrhea, significantly reducing the incidence of this infection.
How similar studies have performed: Previous research has shown promise in developing vaccines for other sexually transmitted infections, but this specific approach for gonorrhea is still in the testing phase.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Hook, Edward — University of Alabama at Birmingham
- Study coordinator: Hook, Edward
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.